Have a personal or library account? Click to login
Methodological Issues in Clinical Drug Development for Essential Tremor Cover

Methodological Issues in Clinical Drug Development for Essential Tremor

Tremor and Other Hyperkinetic Movements
Volume 2 (2012): Issue 0
By: Michael A. Carranza,  Madeline R. Snyder,  Rodger J. Elble,  Angelique E. Boutzoukas and  Theresa A. Zesiewicz  
Open Access
|Aug 2012

References

  1. 1
    DeuschlGBainPBrinMConsensus statement of the Movement Disorder Society on tremor. Ad Hoc Scientific CommitteeMov Disord199813(Suppl 3)2239827589
    Back to article
  2. 2
    LouisEDFerreiraJJHow common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremorMov Disord20102553454110.1002/mds.2283820175185
    Back to article
  3. 3
    DeuschlGElbleREssential tremor-neurodegenerative or nondegenerative disease towards a working definition of ETMov Disord2009242033204110.1002/mds.2275519750493
    Back to article
  4. 4
    DeuschlGRaethjenJHellriegelHElbleRTreatment of patients with essential tremorLancet Neurol20111014816110.1016/S1474-4422(10)70322-721256454
    Back to article
  5. 5
    KollerWCBiaryNConeSDisability in essential tremor: effect of treatmentNeurology1986361001100410.1212/WNL.36.7.10012940473
    Back to article
  6. 6
    BainPGFindleyLJAtchisonPet alAssessing tremor severityJ Neurol Neurosurg Psychiatry1993568688710.1136/jnnp.56.8.8688350102
    Back to article
  7. 7
    ZesiewiczTAElbleRLouisEDet alPractice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology2005642008202010.1212/01.WNL.0000163769.28552.CD15972843
    Back to article
  8. 8
    KollerWCVetere-OverfieldBAcute and chronic effects of propranolol and primidone in essential tremorNeurology1989391587158810.1212/WNL.39.12.15872586774
    Back to article
  9. 9
    SchragAMünchauABhatiaKPet alEssential tremor: an overdiagnosed conditionJ Neurol200024795595910.1007/s00415007005311200689
    Back to article
  10. 10
    JainSLoSELouisEDCommon misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremorArch Neurol2006631100110410.1001/archneur.63.8.110016908735
    Back to article
  11. 11
    Benito-LeonJLouisEDEssential tremor: emerging views of a common disorderNat Clin Pract Neurol200626667810.1038/ncpneuro034717117170
    Back to article
  12. 12
    QuinnNPSchneiderSASchwingenschuhPBhatiaKPTremor-some controversial aspectsMov Disord201126182310.1002/mds.2328921322015
    Back to article
  13. 13
    ElbleRJDeuschlGMilestones in tremor researchMov Disord2011261096110510.1002/mds.2357921626554
    Back to article
  14. 14
    IsaiasIUMarottaGHiranoSet alImaging essential tremorMov Disord20102567968610.1002/mds.2287020437537
    Back to article
  15. 15
    Bermejo-ParejaFEssential tremor—a neurodegenerative disorder associated with cognitive defectsNat Rev Neurol20117110
    Back to article
  16. 16
    FindleyLJKollerWCDefinitions and behavioral classificationsFindleyLJKollerWCHandbook of Tremor DisordersNew YorkDekker199415
    Back to article
  17. 17
    ChandranPPalPKReddyJYCThennarasuKYadavRShivashankarNNon-motor features in essential tremorActa Neurol Scand201212533233710.1111/j.1600-0404.2011.01573.x21777207
    Back to article
  18. 18
    ChouinardSLouisEDFahnSAgreement among movement disorder specialists on the clinical diagnosis of essential tremorMov Disord19971297397610.1002/mds.8701206219399223
    Back to article
  19. 19
    LouisEDOttmanRFordBet alThe Washington Heights-Inwood Genetic Study of Essential Tremor: methodological issues in essential tremor researchNeuroepidemiology19971612413310.1159/0001096819159767
    Back to article
  20. 20
    PahwaRLyonsKHubbleJPet alDouble-blind controlled trial of gabapentin in essential tremorMov Disord19981346546710.1002/mds.8701303159613738
    Back to article
  21. 21
    GiornellAKulisevskyJBarbanokMet alA randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremorArch Neurol19995647548010.1001/archneur.56.4.47510199338
    Back to article
  22. 22
    OndoWHunterCVuongKDet alGabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trialMov Disord20001567868210.1002/1531-8257(200007)15:4<;678::AID-MDS1012>3.0.CO;2-010928578
    Back to article
  23. 23
    Lopezdel ValSantosSGabapentin in the treatment of tremorRev Neurol20033632232612599126
    Back to article
  24. 24
    BainPGMallyJGrestyMFindleyLJAssessing the impact of essential tremor on upper limb functionJ Neurol1993241546110.1007/BF008706738138823
    Back to article
  25. 25
    ZesiewiczTAElbleRJLouisEDet alEvidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology2011771752175510.1212/WNL.0b013e318236f0fd22013182
    Back to article
  26. 26
    BrinMFLyonsKEDoucetteJet alA randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremorNeurology2001561523152810.1212/WNL.56.11.152311402109
    Back to article
  27. 27
    JankovicJSchwartzKClemenceWet alA randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremorMov Disord19961125025610.1002/mds.8701103068723140
    Back to article
  28. 28
    OndoWGJankovicJConnorGSet alTopiramate in essential tremor: a double-blind, placebo-controlled trialNeurology20066667267710.1212/01.wnl.0000200779.03748.0f16436648
    Back to article
  29. 29
    ElbleRJGravitational artifact in accelerometric measurements of tremorClin Neurophysiol20051161638164310.1016/j.clinph.2005.03.01415905122
    Back to article
  30. 30
    ZesiewiczTAWardCLHauserRAet alA double-blind placebo-controlled trial of zonisamide (Zonegram) in the treatment of essential tremorMov Disord20072227928210.1002/mds.2128217149715
    Back to article
  31. 31
    ZesiewiczTAWardCLHauserRAet alA pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremorMov Disord2007221660166310.1002/mds.2162917580330
    Back to article
  32. 32
    HaubenbergerDKalowitzDNahabFBet alValidation of digital spiral analysis as outcome parameter for clinical trials in essential tremorMov Disord2011262073208010.1002/mds.2380821714004
    Back to article
  33. 33
    ElbleRJPullmanSLMatsumotoJYet alTremor amplitude is logarithmically related to 4-point and 5-point tremor rating scalesBrain20061292660266610.1093/brain/awl19016891320
    Back to article
  34. 34
    ZhangKBhatiaSOhMYet alLong-term results of thalamic deep brain stimulation for essential tremorJ Neurosurg20101121271127610.3171/2009.10.JNS0937119911883
    Back to article
  35. 35
    SassoEPeruccaEFavaRCalzettiSPrimidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysisClin Neuropharmacol199013677610.1097/00002826-199002000-000072306749
    Back to article
  36. 36
    CalzettiSSassoEBarattiMFavaRClinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremorActa Neurol Scan199081392610.1111/j.1600-0404.1990.tb00982.x
    Back to article
  37. 37
    Serrano-DuenasMUse of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor. Double-blind comparative study with one-year follow-upParkinsonism Relat Disord200310293310.1016/S1353-8020(03)00070-114499204
    Back to article
  38. 38
    GormanWPCooperRPocockPCampbellMJA comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysisJ Neurol Neurosurg Psychiatry198649646810.1136/jnnp.49.1.643514797
    Back to article
  39. 39
    DeuschlGKollerWCIntroduction. Essential tremorNeurology200054(Suppl 4)S110854343
    Back to article
  40. 40
    FerraraJMKenneyCDavidsonALet alEfficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trialJ Neurol Sci200928519519710.1016/j.jns.2009.06.04419631949
    Back to article
  41. 41
    LorenzDSchweigerDMoisesHDeuschlGQuality of life and personality in essential tremor patientsMov Disord2006211114111810.1002/mds.2088416622851
    Back to article
  42. 42
    TrösterAlPahwaRFieldsJATannerCMLyonsKEQuality of life in essential tremor questionnaire (QUEST): development and initial validationParkinsonism Relat Disord20051136737310.1016/j.parkreldis.2005.05.00916103000
    Back to article
  43. 43
    Martinez-MartinPJimenez-JimenezFJCarrozaGEet alMost of the quality of life in essential tremor questionnaire (QUEST) psychometric properties resulted in satisfactory valuesJ Clin Epidemiol20106376777310.1016/j.jclinepi.2009.09.00119959331
    Back to article
DOI: https://doi.org/10.5334/tohm.116 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 13, 2011
Accepted on: May 30, 2012
Published on: Aug 6, 2012
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Essential tremor,
methodology,
tremor,
etiology

© 2012 Michael A. Carranza, Madeline R. Snyder, Rodger J. Elble, Angelique E. Boutzoukas, Theresa A. Zesiewicz, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 2 (2012): Issue 0Next article